Suppr超能文献

哮喘严重程度和控制的数据库索引的开发与验证。

Development and validation of database indexes of asthma severity and control.

作者信息

Firoozi Faranak, Lemière Catherine, Beauchesne Marie-France, Forget Amélie, Blais Lucie

机构信息

Université de Montréal, Faculté de pharmacie, CP 6128, Succursale Centre-ville, Montreal, Québec, Canada H3C 3J7.

出版信息

Thorax. 2007 Jul;62(7):581-7. doi: 10.1136/thx.2006.061572. Epub 2007 Feb 7.

Abstract

BACKGROUND

The use of administrative databases to perform epidemiological studies in asthma has increased in recent years. The absence of clinical parameters to measure the level of asthma severity and control is a major limitation of database studies. A study was undertaken to develop and validate two database indexes to measure the control and severity of asthma.

METHODS

Database indexes of asthma severity and control were derived from definitions in the Canadian Asthma Consensus Guidelines based on dispensed prescriptions and on medical services recorded in two large administrative databases from the Canadian province of Québec (Régie de l'Assurance Maladie du Québec (RAMQ) and MED-ECHO) over 12 months. The database indexes of asthma severity and control were validated against the pulmonary function test results of 71 patients with asthma randomly selected from two asthma clinics, and they were also applied to a cohort of patients with asthma followed up for 139 283 person-years selected from the RAMQ and MED-ECHO databases between 1 January 1997 and 31 December 2004.

RESULTS

According to the database indexes, 49.3%, 29.6% and 21.1% of patients recruited at the asthma clinics were found to have mild, moderate and severe asthma, respectively, while 53.5% were found to have controlled asthma. The mean predicted value of the forced expiratory volume in 1 s (FEV(1)) ranged from 89.8% for mild asthma to 61.5% for severe asthma (p<0.001), whereas the range from controlled to uncontrolled asthma was 89.5% to 67.3% (p<0.001). The ratio of the FEV(1) to the forced vital capacity (FEV(1)/FVC ratio) measured in 56 patients ranged from 75.8% for mild asthma to 61.8% for severe asthma (p = 0.030), whereas the range from controlled to uncontrolled asthma was 75.3% to 65.7% (p<0.001).

CONCLUSION

In the absence of clinical data, these database indexes could be used in epidemiological studies to assess the severity and control of asthma.

摘要

背景

近年来,利用行政数据库开展哮喘流行病学研究的情况有所增加。缺乏用于衡量哮喘严重程度和控制水平的临床参数是数据库研究的一个主要局限。开展了一项研究以开发并验证两个用于衡量哮喘控制和严重程度的数据库指标。

方法

哮喘严重程度和控制的数据库指标源自《加拿大哮喘共识指南》中的定义,基于12个月内加拿大魁北克省两个大型行政数据库(魁北克医疗保险局(RAMQ)和MED-ECHO)中记录的配药处方和医疗服务。将哮喘严重程度和控制的数据库指标与从两家哮喘诊所随机选取的71例哮喘患者的肺功能测试结果进行验证,并且还将其应用于1997年1月1日至2004年12月31日期间从RAMQ和MED-ECHO数据库选取的随访139283人年的一组哮喘患者。

结果

根据数据库指标,在哮喘诊所招募的患者中,分别有49.3%、29.6%和21.1%被发现患有轻度、中度和重度哮喘,而53.5%被发现哮喘得到控制。一秒用力呼气量(FEV(1))的平均预测值范围为轻度哮喘患者的89.8%至重度哮喘患者的61.5%(p<0.001),而从控制良好到控制不佳的哮喘患者的范围为89.5%至67.3%(p<0.001)。在56例患者中测量的FEV(1)与用力肺活量之比(FEV(1)/FVC比值)范围为轻度哮喘患者的75.8%至重度哮喘患者的61.8%(p = 0.030),而从控制良好到控制不佳的哮喘患者的范围为75.3%至65.7%(p<0.001)。

结论

在缺乏临床数据的情况下,这些数据库指标可用于流行病学研究以评估哮喘的严重程度和控制情况。

相似文献

1
Development and validation of database indexes of asthma severity and control.
Thorax. 2007 Jul;62(7):581-7. doi: 10.1136/thx.2006.061572. Epub 2007 Feb 7.
5
Asthma severity categorization using a claims-based algorithm or pulmonary function testing.
J Asthma. 2009 Feb;46(1):67-72. doi: 10.1080/02770900802503099.
6
Is the Quebec provincial administrative database a valid source for research on chronic non-cancer pain?
Pharmacoepidemiol Drug Saf. 2015 Sep;24(9):980-90. doi: 10.1002/pds.3820. Epub 2015 Jun 24.
7
Quality of life measured by the St George's Respiratory Questionnaire and spirometry.
Eur Respir J. 2009 May;33(5):1025-30. doi: 10.1183/09031936.00116808. Epub 2009 Jan 22.
8
10
Exercise-induced bronchospasm in children: comparison of FEV1 and FEF25-75% responses.
Pediatr Pulmonol. 2003 Jul;36(1):49-54. doi: 10.1002/ppul.10309.

引用本文的文献

3
Association Between Medication Adherence and Risk of COPD in Adult Asthma Patients: A Retrospective Cohort Study in Canada.
Clin Epidemiol. 2022 Oct 27;14:1241-1254. doi: 10.2147/CLEP.S370623. eCollection 2022.
5
Controversies in the treatment of mild asthma. What novelties and practical implications?
Pediatr Allergy Immunol. 2022 Jan;33 Suppl 27(Suppl 27):11-14. doi: 10.1111/pai.13618.
6
Is asthma associated with COVID-19 infection? A UK Biobank analysis.
ERJ Open Res. 2021 Nov 29;7(4). doi: 10.1183/23120541.00309-2021. eCollection 2021 Oct.
7
Intermittent and mild persistent asthma: how therapy has changed.
Acta Biomed. 2021 Nov 29;92(S7):e2021523. doi: 10.23750/abm.v92iS7.12422.
8
Long-Term Natural History of Severe Asthma Exacerbations and Their Impact on the Disease Course.
Ann Am Thorac Soc. 2022 Jun;19(6):907-915. doi: 10.1513/AnnalsATS.202012-1562OC.
9
Asthma Severity and Control and Their Association With Perinatal Mental Illness.
Can J Psychiatry. 2022 Feb;67(2):156-159. doi: 10.1177/07067437211039790. Epub 2021 Aug 26.
10
Trends in oral corticosteroids use in severe asthma: a 14-year population-based study.
Respir Res. 2021 Apr 9;22(1):103. doi: 10.1186/s12931-021-01696-x.

本文引用的文献

1
Socioeconomic status and medication prescription patterns in pediatric asthma in Canada.
J Adolesc Health. 2006 May;38(5):607.e9-16. doi: 10.1016/j.jadohealth.2005.02.010.
2
Use of inhaled corticosteroids during pregnancy and risk of pregnancy induced hypertension: nested case-control study.
BMJ. 2005 Jan 29;330(7485):230. doi: 10.1136/bmj.38313.624352.8F. Epub 2005 Jan 19.
4
Patient and physician evaluation of the severity of acute asthma exacerbations.
Braz J Med Biol Res. 2004 Sep;37(9):1321-30. doi: 10.1590/s0100-879x2004000900006. Epub 2004 Aug 24.
5
Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys.
J Allergy Clin Immunol. 2004 Jul;114(1):40-7. doi: 10.1016/j.jaci.2004.04.042.
6
Asthma severity and asthma control: symptoms, pulmonary function, and inflammatory markers.
Curr Opin Pulm Med. 2004 Jan;10(1):1-6. doi: 10.1097/00063198-200401000-00002.
7
Development of the asthma control test: a survey for assessing asthma control.
J Allergy Clin Immunol. 2004 Jan;113(1):59-65. doi: 10.1016/j.jaci.2003.09.008.
8
Methods of measuring asthma severity and influence on patient assignment.
Ann Allergy Asthma Immunol. 2003 Nov;91(5):449-54. doi: 10.1016/S1081-1206(10)61512-8.
10
Health-related quality of life and future health care utilization for asthma.
Ann Allergy Asthma Immunol. 2002 Jul;89(1):46-55. doi: 10.1016/S1081-1206(10)61910-2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验